XML 80 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Operating activities    
Net income $ 113.9 $ 166.3
Non-cash pre-tax expense:    
Depreciation 60.9 57.1
Amortization 12.3 9.1
Stock-based compensation 23.9 19.8
Recognition of actuarial losses 1.7 5.6
Asset impairment charges   27.4
Loss on sale of discontinued operation 83.2  
Loss on sale of property, plant and equipment 0.5 0.8
Restructuring charges 0.4  
Deferred income taxes 5.6 (0.9)
Changes in assets and liabilities:    
Increase in accounts receivable (77.6) (97.4)
Increase in inventories (34.5) (79.9)
(Decrease) increase in accounts payable (3.6) 40.8
(Increase) decrease in other assets (15.1) 26.2
Decrease in accrued expenses and other liabilities (104.5) (19.9)
Increase in accrued taxes 43.1 11.2
Net cash provided by operating activities 110.2 166.2
Investing activities    
Capital expenditures (82.3) (55.2)
Proceeds from the disposition of assets 0.2 2.1
Proceeds from sale of discontinued operation 130.0  
Cost of acquisitions, net of cash (118.5) (302.0)
Other investing activities (7.0) (0.2)
Net cash used in investing activities (77.6) (355.3)
Financing activities    
Increase in short-term debt, net (2.7) 0.9
Issuance of long-term debt 835.0 220.0
Repayment of long-term debt (505.0) (190.0)
Proceeds from the exercise of stock options 23.1 41.3
Treasury stock purchases (411.4) (43.1)
Excess tax benefit from the exercise of stock-based compensation 24.4 16.5
Dividends to stockholders (58.5) [1] (33.2) [1]
Other financing, net (2.2) (2.6)
Net cash (used in) provided by financing activities (97.3) 9.8
Effect of foreign exchange rate changes on cash (1.6) 0.3
Net decrease in cash and cash equivalents (66.3) (179.0)
Cash and cash equivalents at beginning of period 241.4 336.0
Cash and cash equivalents at end of period $ 175.1 $ 157.0
[1] Excludes dividends declared but not paid of $19.0 million as of September 30, 2014